These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18180604)

  • 1. Quality of life in osteoporotic women with inadequate clinical response to antiresorptive drugs: results from the ICARO study.
    Barbagallo M; Dominguez LJ; Maugeri D; Isaia G; Silvestri S; Bevilacqua M; Adami S;
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):24-7. PubMed ID: 18180604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
    J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
    Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
    QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.
    Oleksik A; Lips P; Dawson A; Minshall ME; Shen W; Cooper C; Kanis J
    J Bone Miner Res; 2000 Jul; 15(7):1384-92. PubMed ID: 10893688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide.
    Maugeri D; Russo E; Luca S; Leotta C; Mamazza G; Sorace R; Rizzotto M; Manuele S; Fiore V; Taverna G; Castiglia B; Calitro M
    Arch Gerontol Geriatr; 2009; 49(1):35-8. PubMed ID: 18555544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.
    Salaffi F; Cimmino MA; Malavolta N; Carotti M; Di Matteo L; Scendoni P; Grassi W;
    J Rheumatol; 2007 Jul; 34(7):1551-60. PubMed ID: 17516618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Back pain treatment in post-menopausal osteoporosis with vertebral fractures.
    Ulivieri FM
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):21-3. PubMed ID: 18180603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and vertebral compression fractures-continued missed opportunities.
    Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
    Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO).
    Koçyigit H; Gülseren S; Erol A; Hizli N; Memis A
    Clin Rheumatol; 2003 Feb; 22(1):18-23. PubMed ID: 12605312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between health-related quality of life domains and bone status in postmenopausal Japanese women.
    Tashiro A; Kakuta H; Tanaka N; Takeuchi Y
    Menopause; 2006; 13(5):846-9. PubMed ID: 16894337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the functioning of women with osteoporosis with vertebral fractures and without vertebral fractures using the Polish version of Qualeffo-41].
    Baczyk G; Opala T; Klejewski A; Tesarska B
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):172-7. PubMed ID: 21038636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden.
    Ström O; Borgstrom F; Zethraeus N; Johnell O; Lidgren L; Ponzer S; Svensson O; Abdon P; Ornstein E; Ceder L; Thorngren KG; Sernbo I; Jonsson B
    Acta Orthop; 2008 Apr; 79(2):269-80. PubMed ID: 18484255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
    Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
    Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The psychometric properties of patient preferences in osteoporosis.
    Cranney A; Coyle D; Pham BA; Tetroe J; Wells G; Jolly E; Tugwell P
    J Rheumatol; 2001 Jan; 28(1):132-7. PubMed ID: 11196515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.